COVID-19 / Coronavirus

Happiness Biotech Provides Update and Guidance on Sales of Its E-Commerce Business

2021-02-17 21:00 7894

NANPING, China, Feb. 17, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that Happy Buy, the Company's wholly-owned subsidiary focusing on e-commerce business, recorded s...

RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107

2021-02-17 20:00 3318

- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...

Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research

2021-02-17 13:00 1395

Timely presentations of trial data will accelerate transition from research to practice LUGANO, Switzerland, Feb. 17, 2021 /PRNewswire/ -- ESMO, the leading organisation for medical oncology, launches an important new service for rapidly disseminating research to accelerate the transition of res...

88% Vaccination Rate Across Yas Island Employees

2021-02-17 09:00 644

Abu Dhabi's leading leisure and entertainment destination to be among the first in the world to vaccinate most of itsemployees, signaling its commitment to health and safety ABU DHABI, UAE, Feb. 17, 2021 /PRNewswire/ -- Eighty-eight per cent employees working at attractions, experiences, hotels,...

Quark Expeditions Adopts Breakthrough Rapid PCR Testing as Part of its S.A.F.E. COVID Policy

2021-02-17 03:19 1446

SEATTLE, Feb. 16, 2021 /PRNewswire/ -- Quark Expeditions, the recognized leader in Polar Adventures, has secured rapid onsite testing capability as part of its industry-leading S.A.F.E. COVID Policy, designed to protect travelers' health—and financial investment—when expedition travel resumes. ...

Deep Longevity Publishes Article About Preventing COVID-19 and Aging

2021-02-16 17:20 4762

HONG KONG, Feb. 16, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group";SEHK: 0575.HK)'s Deep Longevity, Inc, a company acquired on 14 December 2020 which develops artificial intelligence to track human aging and ext...

The Philippines Unveils Unique Advantages in Covid-critical PPE and Medical Supplies Manufacturing at Japanese Business Event

2021-02-16 13:30 2771

COST EFFICIENT, RESILIENT TALENT POOL AND STRATEGIC POLICY REFORMS PROVIDE INVESTMENT OPPORTUNITIES FORJAPAN AND NEIGHOURING MARKETS TOKYO, Feb. 16, 2021 /PRNewswire/ -- Today, the Philippine government in partnership with the Japan Hygiene Products Industry Association (JHPIA) organized an onli...

GenScript Receives FDA Emergency Use Authorization for Use of cPass(TM) SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening

2021-02-11 20:30 1404

PISCATAWAY, N.J., Feb. 11, 2021 /PRNewswire/ -- GenScript USA Inc ., the world's leading life science research tools and services provider, announced today that it has received Emergency Use Authorization by the U.S. Food and ...

Zymo Research Launches COVID-19 Sequencing Service for the Detection and Surveillance of Emerging SARS-CoV-2 Variants

2021-02-11 13:46 3195

Rapid reporting at high throughput enables detection of potential vaccine escaping variant strains IRVINE, Calif., Feb. 11, 2021 /PRNewswire/ -- Zymo Research announced today theirCOVID-19 Variant Sequencing Service. This new global service expands Zymo Research's end-to-end SARS-CoV-2 solutions...

Positivity Around Vaccine Roll-Out and Future Availability Leads to Improved Perceptions on Whole Health

2021-02-11 11:46 10198

HONG KONG, Feb. 11, 2021 /PRNewswire/ -- Cigna's (NYSE:CI) International Markets business today published the fifth edition of its COVID-19 Global Impact Study, which highlights the contrast in well-being around the world as vaccine roll-out commenced for some, while other markets anticipated vac...

Care Journey Orchestration Tackles Healthcare's Biggest Operational Challenges

2021-02-11 00:02 2038

This innovative approach, already used in other industries, helps health systems refactor their costs, shift to be consumer-centric, and make reimbursement predictable, finds Frost & Sullivan SANTA CLARA, Calif., Feb. 11, 2021 /PRNewswire/ -- The economics of healthcare have been adversely affec...

Elekta's ProKnow to help standardize radiotherapy for veterans

2021-02-10 21:25 6023

Cloud-based ProKnow will enable peer review across Veterans Affairs network ATLANTA, Feb. 10, 2021 /PRNewswire/ -- Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with El...

I-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid Tumors

2021-02-10 21:00 5189

SHANGHAI and GAITHERSBURG, Md., Feb. 10, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of the China N...

MGI's "Super Sequencer" Helps Sweden's National Pandemic Center Monitor COVID-19 Mutations

2021-02-10 18:52 1030

STOCKHOLM, Feb. 10, 2021 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI")'s high-throughput gene sequencer has helped the regions throughoutSweden greatly improve their COVID-19 testing capabilities from the laboratory at the National Pandemic Center located inKarolinska Institute (KI). Sweden's STV Ne...

Hong Kong public focuses on financial wellbeing, retirement planning and health amid pandemic, Manulife survey shows

2021-02-10 13:55 3199

* Control of finances more important given concerns about loss of personal wealth * Preference for dealing with agents when buying insurance, although digital on the rise HONG KONG, Feb. 10, 2021 /PRNewswire/ -- A year on from the outbreak of COVID-19,Hong Kong residents are taking more contr...

Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials

2021-02-09 21:53 3286

NEW YORK, Feb. 9, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the award of a grant from The Michael J. Fox Foundation for Parkinson's Research to determine optimal dosing of its lead drug candidate ATH434 for Parkinson's di...

Crisis and Opportunity Coexist: The Battle to Defend the Survival of Online Entertainment in the Pandemic (Part 2) - Interview with Color Star Technology Co., Ltd. (NASDAQ: CSCW)

2021-02-09 21:00 7150

NEW YORK, Feb. 9, 2021 /PRNewswire/ -- Recently, Luke Lu, CEO of Color Star Technology Co., Ltd. (Nasdaq: CSCW) (hereinafter referred to as "CSCW"), accepted an interview with the HK Finet Group. Mr. Lu provided the following responses regarding CSCW's corporate breakthroughs and development in r...

Guide IR Ranks Top 2 in Yole Report as Global Infrared Thermal Imaging Market Explodes

2021-02-09 19:26 2246

WUHAN, China, Feb. 9, 2021 /PRNewswire/ -- Yole Développement, the internationally renowned market survey and strategic consulting firm, has launched its latest industry analysis entitled Thermal Imagers and Detectors 2020 – COVID-19 Outbreak Impact – Preliminary Report. The report reveals that ...

Health Canada provides COVID-19 Interim Order approval for Bactiguard's TempSensor catheter

2021-02-09 16:30 1542

STOCKHOLM , Feb. 9, 2021 /PRNewswire/ -- Health Canada has approved Bactiguard's urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's catheters can reduce the risk of secondary infections for critically ill...

Experiment showed that Jemincare's neutralizing antibody JMB2002 would likely keep the potency against the South African mutant

2021-02-09 11:18 1271

SHANGHAI, Feb. 8, 2021 /PRNewswire/ -- On February 7, 2021, scientists from Jemincare Shanghai Research Institute published a preprint paper on BioRxiv, the paper entitled "A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prop...

1 ... 109110111112113114115 ... 226